Karthigeyan Nanjan,Fadil Al Alawi,Paul Chambers,Kate Hill
申请号：
US12524421
公开号：
US08748467B2
申请日:
2008.01.22
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The invention relates to composition and related therapeutic methods including at least one antihyperthyroid drug formulated for transdermal administration. Because the formulation is formulated for transdermal administration, the formulation is easier to administer than existing formulations which are administered orally to animals. Issues surrounding transdermal administration versus oral administration have also been resolved allowing the agent to remain stable during storage and retain a high level of efficacy.
